Closed system solutions for cell and gene therapy manufacturing
Despite the rapid growth of the cell and gene therapy sector, many challenges remain, including high costs, complex manufacturing processes, and contamination risks. Implementing closed-system solutions can significantly improve efficiency, safety, and cost-effectiveness in cell and gene therapy manufacturing. This article explores the integration of advanced vessels, which allow developers to optimize workflows for cell culture, ultimately enhancing productivity and scalability in cell and gene therapy production.
Institutions
- Corning (United States) (US)
Publication Details
- Journal
- Cell and Gene Therapy Insights
- Published
- 2024-12-05
- DOI
- https://doi.org/10.18609/cgti.2024.179
- Primary Topic
- Viral Infectious Diseases and Gene Expression in Insects
- Type
- article
- Field-Weighted Citation Impact
- 0.00